Search Results for: OSE Immunotherapeutics Signs License Option
Articles
October 9, 2017
OSE Immunotherapeutics Signs License Option Agreement October 9, 2017
OSE Immunotherapeutics SA recently announced it has entered into an agreement with Inserm Transfert, on behalf of Inserm, a French...
November 2, 2017
AC Immune SA to Receive Milestone Payment November 2, 2017
AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, recently...
February 11, 2013
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
